Related Experiment Video
Updated: May 9, 2026
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
FMRP and myelin protein expression in oligodendrocytes
Anthony Giampetruzzi1, John H Carson, Elisa Barbarese
1Department of Neuroscience, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030-3401, USA.
Abstract:
Fragile X syndrome (FXS) is caused by lack of expression of fragile X mental retardation protein (FMRP), the product of the Fmr1 gene. In many cases FXS is associated with abnormalities in CNS myelination. Although FMRP is expressed in oligodendrocyte progenitor cells and immature oligodendrocytes (OLGs) previous studies have not detected it in mature, myelin-producing OLGs. FMRP represses translation of myelin basic protein (MBP) RNA in vitro and is believed to prevent premature MBP expression in immature OLGs. Lack of FMRP in FXS could lead to premature myelination and/or myelin abnormalities. Here we show that FMRP is expressed in mature, MBP-positive OLGs of rodents and in MBP-positive human OLGs. We confirm that FMRP is a translational repressor of MBP mRNA in vitro, but at concentrations likely too high to be physiologically relevant in vivo. We find MBP expression in cultured Fmr1 KO OLGs to be similar to wild type, and expression of MBP and other myelin proteins in brain homogenates of the Fmr1 KO mouse to be similar to wild type before, during, and after the period of active myelination. These results suggest that while FMRP is expressed in mature OLGs, myelin abnormalities caused by lack of FMRP expression in FXS are not recapitulated in rodents.
Insights
Fragile X syndrome (FXS) is linked to CNS myelination issues. However, this study found that lack of FMRP in FXS does not cause myelin abnormalities in rodents.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Fragile X syndrome (FXS) results from FMRP deficiency, impacting CNS myelination.
- FMRP's role in mature oligodendrocytes and its effect on myelin protein expression were previously unclear.
Purpose of the Study:
- To investigate FMRP expression in mature oligodendrocytes.
- To determine if FMRP deficiency causes myelin abnormalities in FXS models.
Main Methods:
- Immunohistochemistry to detect FMRP in mature oligodendrocytes (OLGs) in rodents and humans.
- In vitro assays to assess FMRP's translational repression of myelin basic protein (MBP) mRNA.
- Analysis of MBP and other myelin protein expression in Fmr1 knockout (KO) mouse brains.
Main Results:
- FMRP is present in mature, myelin-producing OLGs in both rodents and humans.
- FMRP represses MBP mRNA translation in vitro, but at potentially non-physiological concentrations.
- MBP and other myelin protein expression levels were similar between Fmr1 KO and wild-type mice during active myelination.
Conclusions:
- FMRP is expressed in mature OLGs, contrary to previous assumptions.
- The proposed mechanism of FMRP preventing premature MBP expression may not be the primary driver of FXS-related myelin issues.
- Rodent models may not fully recapitulate the myelin abnormalities observed in human FXS.
